Heroin-induced conditioned immunomodulation requires expression of IL-1β in the dorsal hippocampus

Brain, Behavior, and Immunity

Volumn 30, Issue , 2013, Pages 95-102

  Szczytkowski, Jennifer L ^a,b   Lebonville, Christina ^a   Hutson, Lee ^a   Fuchs, Rita A ^a   Lysle, Donald T ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b MESSIAH COLLEGE   (United States)

Author keywords

Conditioning; Dorsal hippocampus; Heroin; IL 1; Nitric oxide; SiRNA

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; DIAMORPHINE; INTERLEUKIN 1BETA; NITRIC OXIDE; SMALL INTERFERING RNA;

ARTICLE; BRAIN DEPTH STIMULATION; CAGE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; HIPPOCAMPUS; IMMUNE RESPONSE; IMMUNOMODULATION; LEWIS RAT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CONDITIONING, CLASSICAL; HEROIN; HIPPOCAMPUS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MUSCIMOL; NARCOTICS; NITRIC OXIDE; RATS; RATS, INBRED LEW; RNA, SMALL INTERFERING;

EID: 84876865308     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.01.076     Document Type: Article

References (79)

1. Adler M.W., Geller E.B., Chen X.H., Rogers T.J. Viewing chemokines as a third major system of communication in the brain. Aaps J. 2005, 7:E865-E870.
2. Albina J.E., Henry W.L. Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J. Surg. Res. 1991, 50:403-409.
3. Avital A., Goshen I., Kamsler A., Segal M., Iverfeldt K., Richter-Levin G., Yirmiya R. Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 2003, 13:826-834.
4. Bandaletova T., Brouet I., Bartsch H., Sugimura T., Esumi H., Ohshima H. Immunohistochemical localization of an inducible form of nitric oxide synthase in various organs of rats treated with Propionibacterium acnes and lipopolysaccharide. APMIS: Acta Pathologica, Microbiologica, Immunologica Scandinavica 1993, 101:330-336.
5. Ben Menachem-Zidon O., Avital A., Ben-Menahem Y., Goshen I., Kreisel T., Shmueli E.M., Segal M., Ben Hur T., Yirmiya R. Astrocytes support hippocampal-dependent memory and long-term potentiation via interleukin-1 signaling. Brain Behav. Immun. 2011, 25:1008-1016.
6. Bertotto M.E., Maldonado N.M., Bignante E.A., Gorosito S.V., Cambiasso M.J., Molina V.A., Martijena I.D. Erk activation in the amygdala and hippocampus induced by fear conditioning in ethanol withdrawn rats: modulation by mk-801. Eur. Neuropsychopharm. 2011, 21:892-904.
7. Breitbach K., Klocke S., Tschernig T., van Rooijen N., Baumann U., Steinmetz I. Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect. Immun. 2006, 74:6300-6309.
8. Chao C.C., Ma Y.L., Lee E.H. Brain-derived neurotrophic factor enhances Bcl-xL expression through protein kinase casein kinase 2-activated and nuclear factor kappa B-mediated pathway in rat hippocampus. Brain Pathol. 2011, 21:150-162.
9. Choi J., Hoffman L.A., Rodway G.W., Sethi J.M. Markers of lung disease in exhaled breath: nitric oxide. Biol. Res. Nurs. 2006, 7:241-255.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159.
11. Coussons-Read M.E., Dykstra L.A., Lysle D.T. Pavlovian conditioning of morphine-induced alterations of immune status: evidence for opioid receptor involvement. J. Neuroimmunol. 1994, 55:135-142.
12. Coussons-Read M.E., Dykstra L.A., Lysle D.T. Pavlovian conditioning of morphine-induced alterations of immune status: evidence for peripheral beta-adrenergic receptor involvement. Brain Behav. Immun. 1994, 8:204-217.
13. Coussons M.E., Dykstra L.A., Lysle D.T. Pavlovian conditioning of morphine-induced alterations of immune status. J. Neuroimmunol. 1992, 39:219-230.
14. Davis C.N., Tabarean I., Gaidarova S., Behrens M.M., Bartfai T. IL-1beta induces a MyD88-dependent and ceramide-mediated activation of Src in anterior hypothalamic neurons. J. Neurochem. 2006, 98:1379-1389.
15. Del-Fava F., Hasue R.H., Ferreira J.G.P., Shammah-Lagnado S.J. Efferent connections of the rostral linear nucleus of the ventral tegmental area in the rat. Neuroscience 2007, 145:1059-1076.
16. Fanselow M.S., Dong H.W. Are the dorsal and ventral hippocampus functionally distinct structures?. Neuron 2010, 65:7-19.
17. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 1996, 276:626-636.
18. Flannery S., Bowie A.G. The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling. Biochem. Pharmacol. 2010, 80:1981-1991.
19. Fuchs R.A., Eaddy J.L., Su Z.I., Bell G.H. Interactions of the basolateral amygdala with the dorsal hippocampus and dorsomedial prefrontal cortex regulate drug context-induced reinstatement of cocaine-seeking in rats. Eur. J. Neurosci. 2007, 26:487-498.
20. Fuchs R.A., Evans K.A., Ledford C.C., Parker M.P., Case J.M., Mehta R.H., See R.E. The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology 2005, 30:296-309.
21. Goshen I., Kreisel T., Ounallah-Saad H., Renbaum P., Zalzstein Y., Ben-Hur T., Levy-Lahad E., Yirmiya R. A dual role for interleukin-1 in hippocampal-dependent memory processes. Psychoneuroendocrine 2007, 32:1106-1115.
22. Green S.J., Mellouk S., Hoffman S.L., Meltzer M.S., Nacy C.A. Cellular mechanisms of nonspecific immunity to intracellular infection: cytokine-induced synthesis of toxic nitrogen oxides from l-arginine by macrophages and hepatocytes. Immunol. Lett. 1990, 25:15-19.
23. Green S.J., Nacy C.A., Schreiber R.D., Granger D.L., Crawford R.M., Meltzer M.S., Fortier A.H. Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from l-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice. Infect. Immun. 1993, 61:689-698.
24. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L., Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Nat. Acad. Sci. USA 1989, 86:7611-7615.
25. Guasch R.M., Blanco A.M., Perez-Arago A., Minambres R., Talens-Visconti R., Peris B., Guerri C. RhoE participates in the stimulation of the inflammatory response induced by ethanol in astrocytes. Exp. Cell Res. 2007, 313:3779-3788.
26. Hibbs J.B., Vavrin Z., Taintor R.R. l-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 1987, 138:550-565.
27. Hrabak A., Csuka I., Bajor T., Csatary L.K. The cytotoxic anti-tumor effect of MTH-68/H, a live attenuated Newcastle disease virus is mediated by the induction of nitric oxide synthesis in rat peritoneal macrophages in vitro. Cancer Lett. 2006, 231:279-289.
28. Huang Y., Smith D.E., Ibanez-Sandoval O., Sims J.E., Friedman W.J. Neuron-specific effects of interleukin-1beta are mediated by a novel isoform of the IL-1 receptor accessory protein. J. Neurosci. 2011, 31:18048-18059.
29. Hussey H.H., Katz S. Infections resulting from narcotic addiction; report of 102 cases. Am. J. Med. 1950, 9:186-193.
30. Ikemoto S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res. Rev. 2007, 56:27-78.
31. Karupiah G., Xie Q.W., Buller R.M., Nathan C., Duarte C., MacMicking J.D. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 1993, 261:1445-1448.
32. Lasseter H.C., Wells A.M., Xie X.H., Fuchs R.A. Interaction of the Basolateral Amygdala and Orbitofrontal Cortex is Critical for drug context-induced reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology 2011, 36:711-720.
33. Liew F.Y. Regulation of nitric oxide synthesis in infectious and autoimmune diseases. Immunol. Lett. 1994, 43:95-98.
34. Lindgren H., Stenmark S., Chen W., Tarnvik A., Sjostedt A. Distinct roles of reactive nitrogen and oxygen species to control infection with the facultative intracellular bacterium Francisella tularensis. Infect. Immun. 2004, 72:7172-7182.
35. Louria D.B., Hensle T., Rose J. The major medical complications of heroin addiction. Ann. Intern. Med. 1967, 67:1-22.
36. Luecken L.J., Lysle D.T. Evidence for the involvement of beta-adrenergic receptors in conditioned immunomodulation. J. Neuroimmunol. 1992, 38:209-219.
37. Luttgens W.F. Endocarditis in main line opium addicts; report on 11 cases. Arch Intern Med (Chic) 1949, 83:653-664.
38. Lysle D.T., Cunnick J.E., Fowler H., Rabin B.S. Pavlovian conditioning of shock-induced suppression of lymphocyte reactivity: acquisition, extinction, and preexposure effects. Life Sci. 1988, 42:2185-2194.
39. Lysle D.T., Hoffman K.E., Dykstra L.A. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. J. Pharmacology Exp. Ther. 1996, 277:1533-1540.
40. Lysle D.T., How T. Heroin modulates the expression of inducible nitric oxide synthase. Immunopharmacology 2000, 46:181-192.
41. Lysle D.T., Ijames S.G. Heroin-associated environmental stimuli modulate the expression of inducible nitric oxide synthase in the rat. Psychopharmacology 2002, 164:416-422.
42. MacMicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., Stevens K., Xie Q.W., Sokol K., Hutchinson N., et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995, 81:641-650.
43. Marcinkiewicz J., Chain B.M. Differential regulation of cytokine production by nitric oxide. Immunology 1993, 80:146-150.
44. Maren S., Holt W.G. The hippocampus and contextual memory retrieval in Pavlovian fear conditioning. Integr. Physol. Behav. Sci. 1999, 34:123-124.
45. Mcdonald A.J. Topographical organization of amygdaloid projections to the caudatoputamen, nucleus-accumbens, and related striatal-like areas of the rat-brain. Neuroscience 1991, 44:15-33.
46. McPherson C.A., Aoyama M., Harry G.J. Interleukin (IL)-1 and IL-6 regulation of neural progenitor cell proliferation with hippocampal injury: differential regulatory pathways in the subgranular zone (SGZ) of the adolescent and mature mouse brain. Brain Behav. Immun. 2011, 25:850-862.
47. Murray H.W., Nathan C.F. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med. 1999, 189:741-746.
48. Oates J.C., Gilkeson G.S. The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clin. Immunol. 2006, 121:243-250.
49. Orangio G.R., Pitlick S.D., Della Latta P., Mandel L.J., Marino C., Guarneri J.J., Giron J.A., Margolis I.B. Soft tissue infections in parenteral drug abusers. Ann. Surg. 1984, 199:97-100.
50. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego.
51. Phillips R.G., Ledoux J.E. Lesions of the dorsal hippocampal-formation interfere with background but not foreground contextual fear conditioning. Learn Memory 1994, 1:34-44.
52. Ramirez D.R., Bell G.H., Lasseter H.C., Xie X.O., Traina S.A., Fuchs R.A. Dorsal hippocampal regulation of memory reconsolidation processes that facilitate drug context-induced cocaine-seeking behavior in rats. Eur. J. Neurosci. 2009, 30:901-912.
53. Redish A.D. The hippocampal debate: are we asking the right questions?. Behav. Brain Res. 2001, 127:81-98.
54. Ringwood L., Li L. The involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammation. Cytokine 2008, 42:1-7.
55. Ross F.M., Allan S.M., Rothwell N.J., Verkhratsky A. A dual role for interleukin-1 in LTP in mouse hippocampal slices. J. Neuroimmunol. 2003, 144:61-67.
56. Rossi G.R., Cervi L.A., Garcia M.M., Chiapello L.S., Sastre D.A., Masih D.T. Involvement of nitric oxide in protecting mechanism during experimental cryptococcosis. Clin. Immunol. 1999, 90:256-265.
57. Rothwell N.J. Functions and Mechanisms of Interleukin-1 in the brain. Trends Pharmacol. Sci. 1991, 12:430-436.
58. Saurer T.B., Ijames S.G., Lysle D.T. Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations. J. Pharmacol. Exp. Ther. 2009, 329:1040-1047.
59. Schmid A.W., Lynch M.A., Herron C.E. The effects of IL-1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo. Hippocampus 2009, 19:670-676.
60. Schneider H., Pitossi F., Balschun D., Wagner A., del Rey A., Besedovsky H.O. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc. Nat. Acad. Sci. USA 1998, 95:7778-7783.
61. Simonovska N., Chibishev A., Bozinovska C., Grcevska L., Dimitrovski K., Neceva V. Evaluation of circulating immune complexes and antiphospholipid antibodies (anti beta 2 glycoprotein 1) in heroin addicts and their clinical significance. Med. Arh. 2011, 65:324-326.
62. Stofkova A., Skurlova M., Tybitanclova K., Veselsky L., Zelezna B., Jurcovicova J. Relationship among nitric oxide, leptin, ACTH, corticosterone, and IL-1beta, in the early and late phases of adjuvant arthritis in male Long Evans rats. Life Sci. 2006, 79:2486-2491.
63. Szczytkowski J.L., Fuchs R.A., Lysle D.T. Ventral tegmental area-basolateral amygdala-nucleus accumbens shell neurocircuitry controls the expression of heroin-conditioned immunomodulation. J. Neuroimmunol. 2011, 237:47-56.
64. Szczytkowski J.L., Lysle D.T. Conditioned effects of heroin on the expression of inducible nitric oxide synthase in the rat are susceptible to extinction and latent inhibition. Psychopharmacology 2007, 191:879-889.
65. Szczytkowski J.L., Lysle D.T. Conditioned effects of heroin on proinflammatory mediators require the basolateral amygdala. Eur. J. Neurosci. 2008, 28:1867-1876.
66. Szczytkowski J.L., Lysle D.T. Dopamine D1 receptors within the basolateral amygdala mediate heroin-induced conditioned immunomodulation. J. Neuroimmunol. 2010, 226:38-47.
67. Taylor-Robinson A.W., Liew F.Y., Severn A., Xu D., McSorley S.J., Garside P., Padron J., Phillips R.S. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 1994, 24:980-984.
68. Theodorou S., Haber P.S. The medical complications of heroin use. Curr. Opin. Psychiatr. 2005, 18:257-263.
69. Tsai W.C., Strieter R.M., Zisman D.A., Wilkowski J.M., Bucknell K.A., Chen G.H., Standiford T.J. Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect. Immun. 1997, 65:1870-1875.
70. Tsakiri N., Kimber I., Rothwell N.J., Pinteaux E. Interleukin-1-induced interleukin-6 synthesis is mediated by the neutral sphingomyelinase/Src kinase pathway in neurones. Br. J. Pharmacol. 2008, 153:775-783.
71. Van Dervort A.L., Yan L., Madara P.J., Cobb J.P., Wesley R.A., Corriveau C.C., Tropea M.M., Danner R.L. Nitric oxide regulates endotoxin-induced TNF-alpha production by human neutrophils. J. Immunol. 1994, 152:4102-4109.
72. Vincendeau P., Daulouede S., Veyret B., Darde M.L., Bouteille B., Lemesre J.L. Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Exp. Parasitol. 1992, 75:353-360.
73. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., Binaglia M., Corsini E., Di Luca M., Galli C.L., Marinovich M. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 2003, 23:8692-8700.
74. Weber A., Wasiliew P., Kracht M. Interleukin-1 (IL-1) pathway. Sci. Signaling 2010, 3. cm1.
75. Weber R.J., Pert A. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 1989, 245:188-190.
76. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., Xu D., Muller W., Moncada S., Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995, 375:408-411.
77. White A.G. Medical disorders in drug addicts. 200 consecutive admissions. JAMA 1973, 223:1469-1471.
78. Yabuuchi K., Minami M., Katsumata S., Satoh M. Localization of type-I interleukin-1 receptor messenger-Rna in the rat-brain. Mol. Brain Res. 1994, 27:27-36.
79. Zhang R., Sun L., Hayashi Y., Liu X., Koyama S., Wu Z., Nakanishi H. Acute p38-mediated inhibition of NMDA-induced outward currents in hippocampal CA1 neurons by interleukin-1beta. Neurobiol. Dis. 2010, 38:68-77.